Holme S, Heaton A, Roodt J
American Red Cross, Mid-Atlantic Region, Norfolk, VA 23501.
Br J Haematol. 1993 Aug;84(4):717-23. doi: 10.1111/j.1365-2141.1993.tb03151.x.
The precision and reproducibility of 111In and 51Cr platelet radiolabel agents for in vivo kinetic studies of stored platelet concentrates (PC) were investigated. The objective was to develop a precise method with concurrent labelling of two platelet populations using different isotopes, which would allow identification of small differences in in vivo platelet quality. Identical labelling procedures were used to investigate the effects of PC storage age, different methods of red cell (RBC) and white cell (WBC) contamination correction, and label elution correction on the results of 111In and 51Cr kinetic studies. 111In and 51Cr platelet survival curves from the same PC, even when uncorrected for elution and RBC contamination, exhibited excellent correlation, irrespective of the age of the concentrate and its viability. However, slightly higher, but statistically significant, post-infusion per cent recoveries with 51Cr labelled platelets were found. Two factors were identified as the cause for this difference. There was a higher affinity of contaminating RBC/WBC in PC for 51Cr than for 111In. With determination of RBC/WBC activity by centrifugation/density separation, RBC/WBC fractions from the injectate were found to contain 12.6 +/- 3.8% v 7.1 +/- 3.6% of total 51Cr and 111In activity, respectively, in 20 studies. In addition, there was a significantly higher 111In activity in plasma immediately post-infusion than with 51Cr, 5.2 +/- 1.3% v 2.8 +/- 1.6%, respectively, suggesting more label elution or carryover. After correction for the activity of RBC/WBC and for elution or carryover, essentially identical 51Cr/111In platelet survival curves were found. In 31 stored PC studies, the absolute average difference between 51Cr and 111In per cent recoveries was only 4 +/- 3% in a group of donors whose platelet recoveries ranged from 10% to 80%. Similarly, the average difference between 51Cr and 111In survival was only 8 +/- 4 h within a range of survivals from 40 to 220 h. In conclusion, after correction for elution and contaminating RBC/WBC binding, these studies show that 51Cr and 111In may be used interchangeably for labelling of stored PC, and that small differences between test and control platelets could be reliably detected using concurrent labelling with simultaneous infusion.
研究了用于储存血小板浓缩物(PC)体内动力学研究的111铟和51铬血小板放射性标记剂的精度和可重复性。目的是开发一种精确的方法,使用不同的同位素同时标记两个血小板群体,从而能够识别体内血小板质量的微小差异。采用相同的标记程序,研究了PC储存时间、不同的红细胞(RBC)和白细胞(WBC)污染校正方法以及标记洗脱校正对111铟和51铬动力学研究结果的影响。即使未对洗脱和RBC污染进行校正,来自同一PC的111铟和51铬血小板存活曲线也呈现出极好的相关性,无论浓缩物的储存时间及其活力如何。然而,发现51铬标记的血小板在输注后的回收率略高,但具有统计学意义。确定了造成这种差异的两个因素。PC中污染的RBC/WBC对51铬的亲和力高于对111铟的亲和力。通过离心/密度分离测定RBC/WBC活性,在20项研究中发现,注射剂中的RBC/WBC组分分别含有51铬和111铟总活性的12.6±3.8%和7.1±3.6%。此外,输注后立即在血浆中的111铟活性明显高于51铬,分别为5.2±1.3%和2.8±1.6%,表明洗脱或残留更多。在校正RBC/WBC活性以及洗脱或残留后,发现51铬/111铟血小板存活曲线基本相同。在31项储存PC研究中,一组血小板回收率在10%至80%之间的供体中,51铬和111铟回收率的绝对平均差异仅为4±3%。同样,在40至220小时的存活范围内,51铬和111铟存活的平均差异仅为8±4小时。总之,在校正洗脱和污染的RBC/WBC结合后,这些研究表明51铬和111铟可互换用于储存PC的标记,并且使用同时标记和同时输注能够可靠地检测测试血小板和对照血小板之间的微小差异。